PARC: a Phase I/II Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase BCT-100 in Relapsed/refractory Cancers of Children and Young Adults
FRONTIERS IN ONCOLOGY(2024)
Key words
arginase,arginine,pediatric,cancer,relapse
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined